Concepedia

Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation

Huan Chen, Lan‐Ping Xu, Xiaohui Zhang, Yu Wang, Yu‐Hong Chen, Chen-Hua Yan, Cheng Yi-fei, Wei Han, Yao Chen, Ya-Zhen Qin,

Leukemia Research · 2022 · 20 citations · 23 references

DOI

Concepts

References

23

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

, , +17

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio et al. · Blood · 2018 · 845 citations · Full text

, , +13

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura et al. · Journal of Clinical Oncology · 2005 · 454 citations · Full text

, , +15

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

D-H Liu, K-Y Liu, L-P Xu et al. · Bone Marrow Transplantation · 2006 · 436 citations

, , +14

Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency

Neil P. Shah, Brian J. Skaggs, Susan Branford et al. · Journal of Clinical Investigation · 2007 · 415 citations · Full text

, , +13